Novel Biomarkers for Thrombosis Risk Prediction in Non–Small-Cell Lung Cancer: Insights from Recent Evidence
Venous thromboembolism (VTE) represents a significant cause of morbidity and mortality in patients with cancer,...
Most Read
VTE management for palliative cancer patients
In his talk “Management of Blood Clots in Palliative Cancer Patients,” delivered within the context of the...
SAVE THE DATE – The 13th International Conference on Thrombosis and Hemostasis Issues in Cancer
The 13th International Conference on Thrombosis and Hemostasis Issues in Cancer (ICTHIC) will next be...
Awareness of venous thromboembolism risk in cancer patients: the oncologist knowledge gap
The management of cancer-associated venous thrombosis (CAT) is particularly challenging because of a high risk of major...
Arterial Thromboembolism in Occult Cancer
In 1865, Armand Trousseau famously described unexplained thrombotic events as a first manifestation of occult...
Measurement of extracellular vesicles and their role in cancer-associated thrombosis
Extracellular vesicles (EV) are submicron vesicles released from activated cells, apoptotic cells and cancer cells...
Risk factors and prevention of venous thromboembolism in ambulatory cancer patients requiring chemotherapy
Epidemiology and risk factors Venous thromboembolism (VTE) is a burdensome and frequent complication in patients with...
Prediction of disease progression and mortality in patients with metastatic gastrointestinal cancer: the role of thrombin generation and D-dimer
Gastrointestinal (GI) cancers represent 26% of the global cancer incidence and more than one-third of all...
Cancer-associated thrombosis in children
Venous thromboembolism (VTE) is one of the leading causes of death in adult cancer patients and represents a challenge...
CAT management: challenges in different cancer populations
Our speakers, Walter Ageno, Florian Scotté, and Darko Antic, shared some insights on...